Publication Records

ŽOURKOVÁ, Alexandra, Jan JUŘICA, Eva MCCASKEY HADAŠOVÁ and Lucie PULKRÁBKOVÁ. Fading of the inhibition of CYP2D6 after paroxetine treatment discontinuation. European Neuropsychopharmacology. Elsevier, 2008, vol. 18, suppl.4, p. S328-S329, 2 pp. ISSN 0924-977X.

PALČÍKOVÁ, Ivana, Alexandra ŽOURKOVÁ, Daria VALENTOVÁ and Eva HADAŠOVÁ. Mental bulimia , paroxetine treatment and phenotype monitoring of CYP2D6 activity. In Addiction and Eating Disorders, Neurobiology nad Comorbidities, Workshop. Brno: Masaryk University Conference Centre, Czech Republic, Brno, 2007, p. 59-60. ISBN 978-80-87041-18-5.

PALČÍKOVÁ, Ivana, Alexandra ŽOURKOVÁ, Eva HADAŠOVÁ, Daria VALENTOVÁ and Barbora RAVČUKOVÁ. Mentální bulimie a léčba paroxetinem, sledování aktivity CYP2D6 (Mental bulimia and paroxetine treatment, monitoring CYP2D6 activity). Psychiatrie. Praha: TIGIS, 2007. ISSN 1211-7579.

PALČÍKOVÁ, Ivana, Alexandra ŽOURKOVÁ and Daria VALENTOVÁ. Sledování aktivity CYP2D6 u pacientek s mentální bulimií (vliv na jídlení chování a sexuální aktivitu) (Bulimia Nervosa and CYP2D6 Activity (Influence on Eating Behaviour and Sexual Acitivty)). Česká a slovenská psychiatrie. Praha: Česká lékařská společnost J.E.Purkyně, 2007, vol. 11, suppl.1, p. 36-37. ISSN 1212-0383.

HADAŠOVÁ, Eva, Alexandra ŽOURKOVÁ, Josef TOMANDL and Barbora RAVČUKOVÁ. Dynamics of CYP2D6 activity and clinical response to paroxetine, alprazolam and their combination in patients with depressive disorder. Chemické listy. Praha: Česká spol. chemická, 2003, 97 (S), červen, p. S180, 1 pp. ISSN 0009-2770.

ŽOURKOVÁ, Alexandra and Eva HADAŠOVÁ. Paroxetine-Induced Conversion of Cytochrome P450 2D6 Phenotype and Occurence of Adverse Effects. General Physiology and Biophysics. Bratislava: Slovak Academy of Sciences, 2003, vol. 22, No 2, p. 103-113. ISSN 0231-5882.

ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ, Marie TOMANDLOVÁ and Miroslav ROBEŠ. Klinický význam CYP 2D6 v průběhu léčby novějšími antidepresivy /Abstrakt/ (Clinical impact of CYP2D6 during treatment with newer antidepressants /Abstract/). Psychiatrie. Praha: TIGIS, 2002, vol. 6, Suppl. 1, p. 46. ISSN 1211-7579.

ŽOURKOVÁ, Alexandra and Eva HADAŠOVÁ. Relation between sexual dysfunctions and CYP 2D6 activity. European psychiatry. Paris, France: Elsevier, 2002, vol. 17, Suppl. 1, p. 190s, 1 pp. ISSN 0924-9338.

ŽOURKOVÁ, Alexandra and Eva HADAŠOVÁ. Relationship Between CYP 2D6 Metabolic Status and Sexual Dysfunction in Paroxetine Treatment. Journal of Sex and Marital Therapy. Philadelphia,USA: Taylor and Francis Health Sciences, 2002, vol. 28, No 5, p. 451-461. ISSN 0092-623X.

BOUŘ, Petr, Hana NAVRÁTILOVÁ, Marie URBANOVÁ, Vladimír SETNIČKA and Karel VOLKA. (3R,4S)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine: Conformation and structure monitoring by vibrational circular dichroism. Journal of Organic Chemistry. 2002, vol. 67, No 1, p. 161-168. ISSN 0022-3263.

NAVRÁTILOVÁ, Hana. Enantiomeric analysis of (3S,4R)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by 19F NMR spectroscopy. Magnetic Resonance in Chemistry. Great Britain: Willey and Sons, Ltd., 2001, vol. 39, No 11, p. 727-730. ISSN 0749-1581.

NAVRÁTILOVÁ, Hana and Milan POTÁČEK. Enantiomeric enrichment of (+)-(3R,4S)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by crystallization. Enantiomer. 2001, vol. 6, No 6, p. 333-338. ISSN 1024-2430.

NAVRÁTILOVÁ, Hana. Use of S-Mosher acid as a chiral solvating agent for enantiomeric analysis of some trans-4-(4-fluorophenyl)-3-substituted-1-methylpiperidines by means of NMR spectroscopy. Chirality. USA: Willey-Liss, 2001, vol. 13, No 10, p. 731-735. ISSN 0899-0042.

ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ, Marta VÁVROVÁ, Miroslav ROBEŠ and Marie VOJTÍŠKOVÁ. Vedlejší účinky léčby paroxetinem v závislosti na aktivitě CYP 2D6 (The relation of side-effects of treatment by paroxetine to CYP 2D6 activity). Psychiatrie. Praha: Tigis, 2001, vol. 5, Suppl. 2, p. 149-151. ISSN 1211-7579.

ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ and Miroslav ROBEŠ. Vztah mezi EM a PM CYP 2D6 ve výskytu sexuálních dysfunkcí (The relation between EM and PM CYP 2D6 in sexual dysfunction). Psychiatrie. Praha: Tigis, 2001, vol. 5, Suppl. 2, p. 148-149. ISSN 1211-7579.

CHARVÁTOVÁ, Zuzana, Kateřina NERUŠILOVÁ, Eva HADAŠOVÁ and Marie HYKSOVÁ. Changes in CYP2D1 activity after pretreatment of rats with fluoxetine and paroxetine. Homeostasis. Praha: Cians, 2000, vol. 40, 1-2, p. 40-43. ISSN 0960-7560.

ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ and Marie VOJTÍŠKOVÁ. Metabolický genotyp a fenotyp CYP 2D6 při léčbě paroxetinem. (Metabolic genotype and fenotype CYP 2D6 in treatment with paroxetine). In Psychiatrie pro XXI. století. 1st ed. Praha: Galén, 2000, p. 138. ISBN 80-86257-18-5.